Skip to main content
Top
Published in: Endocrine 1/2012

01-02-2012 | Original Article

A hypertriglyceridemic state increases high sensitivity C-reactive protein of Japanese men with normal glucose tolerance

Authors: Kyoko Okada, Norihiro Furusyo, Masayuki Murata, Yasunori Sawayama, Mosaburo Kainuma, Jun Hayashi

Published in: Endocrine | Issue 1/2012

Login to get access

Abstract

Both fasting and postprandial hypertriglyceridemia have been identified as risk markers for cardiovascular disease. High-sensitivity C-reactive protein (hs-CRP), known to independently predict future cardiovascular disease, has also been reported to be a direct participant in the progression of atherosclerosis. We evaluated whether or not fasting and/or postprandial hypertriglyceridemia influence hs-CRP of men with normal glucose tolerance. According to the triglyceride (TG) level, measured before and 1 and 2 h after a meal tolerance test, subjects were classified into a normotriglyceridemic (NTG) group (n = 86), a postprandial hypertriglyceridemia (PHTG) group (n = 50), or a fasting hypertriglyceridemia (FHTG) group (n = 53). Hs-CRP and HOMA-R were significantly higher in the FHTG group than in the other groups (P < 0.01). The PHTG group had higher hs-CRP than the NTG group (P < 0.05). No significant differences in age, BMI, LDL cholesterol, or carotid intima-media thickness were found in comparison of the three groups. Multivariate linear regression analysis showed that the area under the TG curve (AUC-TG), HbA1c, and BMI were independently correlated with hs-CRP (P < 0.001, P = 0.016, P = 0.032, respectively). Our data suggests that a hypertriglyceridemic state is associated with hs-CRP irrespective of BMI, LDL-C, and HDL-C, indicating that hs-CRP might represent chronic inflammation induced by hypertriglyceridemia in Japanese men with normal glucose tolerance.
Literature
1.
go back to reference G. Assmann, H. Schulte, A. von Eckardstein, Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am. J. Cardiol. 77, 1179–1184 (1996)PubMedCrossRef G. Assmann, H. Schulte, A. von Eckardstein, Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men. Am. J. Cardiol. 77, 1179–1184 (1996)PubMedCrossRef
2.
go back to reference N. Sarwar, J. Danesh, G. Eiriksdottir et al., Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation 115, 450–458 (2007)PubMedCrossRef N. Sarwar, J. Danesh, G. Eiriksdottir et al., Triglycerides and the risk of coronary heart disease: 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies. Circulation 115, 450–458 (2007)PubMedCrossRef
3.
go back to reference B.G. Nordestgaad, M. Benn, P. Schnohr et al., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299–308 (2007)CrossRef B.G. Nordestgaad, M. Benn, P. Schnohr et al., Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299–308 (2007)CrossRef
4.
go back to reference K. Kugiyama, H. Doi, K. Takazoe et al., Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99, 2858–2860 (1999)PubMed K. Kugiyama, H. Doi, K. Takazoe et al., Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation 99, 2858–2860 (1999)PubMed
5.
go back to reference C.M. Albert, J. Ma, N. Rifai et al., Prospective study of C-reactive protein, homocystein, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105, 2595–2599 (2002)PubMedCrossRef C.M. Albert, J. Ma, N. Rifai et al., Prospective study of C-reactive protein, homocystein, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105, 2595–2599 (2002)PubMedCrossRef
6.
go back to reference P.M. Ridker, M.J. Stampfer, N. Rifai et al., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocystein, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481–2485 (2001)PubMedCrossRef P.M. Ridker, M.J. Stampfer, N. Rifai et al., Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocystein, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285, 2481–2485 (2001)PubMedCrossRef
7.
go back to reference P.M. Ridker, N. Rifai, L. Rose et al., Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557–1565 (2002)PubMedCrossRef P.M. Ridker, N. Rifai, L. Rose et al., Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347, 1557–1565 (2002)PubMedCrossRef
8.
go back to reference Y. Harano, T. Miyawaki, J. Nabiki et al., Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr. J. 53, 173–180 (2006)PubMedCrossRef Y. Harano, T. Miyawaki, J. Nabiki et al., Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr. J. 53, 173–180 (2006)PubMedCrossRef
9.
go back to reference K. Okada, N. Maeda, K. Kikuchi et al., Pravastatin improves insulin resistance in dyslipidemic patients. J. Atheroscler. Thromb. 12, 322–329 (2005)PubMedCrossRef K. Okada, N. Maeda, K. Kikuchi et al., Pravastatin improves insulin resistance in dyslipidemic patients. J. Atheroscler. Thromb. 12, 322–329 (2005)PubMedCrossRef
10.
go back to reference N. Furusyo, Y. Sawayama, S. Maeda et al., High-molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C-virus infection. Hepatol. Res. 37, 1052–1061 (2007)PubMedCrossRef N. Furusyo, Y. Sawayama, S. Maeda et al., High-molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C-virus infection. Hepatol. Res. 37, 1052–1061 (2007)PubMedCrossRef
11.
go back to reference The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol. Int. 1, 2–20 (2010) The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol. Int. 1, 2–20 (2010)
12.
go back to reference K. Okada, N. Maeda, M. Tatsukawa et al., The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population. Atherosclerosis 173, 329–337 (2004)PubMedCrossRef K. Okada, N. Maeda, M. Tatsukawa et al., The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population. Atherosclerosis 173, 329–337 (2004)PubMedCrossRef
13.
go back to reference M. Emoto, Y. Nishizawa, K. Maekawa et al., Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22, 818–822 (1999)PubMedCrossRef M. Emoto, Y. Nishizawa, K. Maekawa et al., Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22, 818–822 (1999)PubMedCrossRef
14.
go back to reference P.M. Ridker, Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369 (2003)PubMedCrossRef P.M. Ridker, Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107, 363–369 (2003)PubMedCrossRef
15.
go back to reference P.M. Ridker, E. Danielson, F.A. Fonseca et al., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008)PubMedCrossRef P.M. Ridker, E. Danielson, F.A. Fonseca et al., Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 359, 2195–2207 (2008)PubMedCrossRef
16.
go back to reference W.G. Thompson, G.T. Gau, Hypertriglyceridemia and its pharmacologic treatment among US adults—invited commentary. Arch. Intern. Med. 23, 578–579 (2009)CrossRef W.G. Thompson, G.T. Gau, Hypertriglyceridemia and its pharmacologic treatment among US adults—invited commentary. Arch. Intern. Med. 23, 578–579 (2009)CrossRef
17.
go back to reference Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, N. Sarwar, M.S. Sandhu et al., Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375, 1634–1639 (2010) Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, N. Sarwar, M.S. Sandhu et al., Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375, 1634–1639 (2010)
18.
go back to reference G. Pare, S.S. Anand, Mendelian randomization, triglycerides, and CHD. Lancet 375, 1584–1586 (2010)PubMedCrossRef G. Pare, S.S. Anand, Mendelian randomization, triglycerides, and CHD. Lancet 375, 1584–1586 (2010)PubMedCrossRef
19.
go back to reference D.B. Zilversmit, Atherogenesis: a postprandial phenomenon. Circulation 60, 473–485 (1979)PubMed D.B. Zilversmit, Atherogenesis: a postprandial phenomenon. Circulation 60, 473–485 (1979)PubMed
20.
go back to reference G.D. Kolovou, K.K. Anagnostopoulou, S.S. Daskalopoulpu et al., Clinical relevance of postprandial lipaemia. Curr. Med. Chem. 12, 1931–1945 (2005)PubMedCrossRef G.D. Kolovou, K.K. Anagnostopoulou, S.S. Daskalopoulpu et al., Clinical relevance of postprandial lipaemia. Curr. Med. Chem. 12, 1931–1945 (2005)PubMedCrossRef
21.
go back to reference S. Teno, Y. Uto, H. Nagashima et al., Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23, 1401–1406 (2000)PubMedCrossRef S. Teno, Y. Uto, H. Nagashima et al., Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes. Diabetes Care 23, 1401–1406 (2000)PubMedCrossRef
22.
go back to reference H. Arima, M. Kubo, K. Yonemoto et al., High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler. Thromb. Vasc. Biol. 28, 1385–1391 (2008)PubMedCrossRef H. Arima, M. Kubo, K. Yonemoto et al., High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study. Arterioscler. Thromb. Vasc. Biol. 28, 1385–1391 (2008)PubMedCrossRef
23.
go back to reference M.A. Albert, R.J. Glynn, J. Buring et al., C-reactive protein levels among women of various ethnic groups living in the United States (from the Women’s Health Study). Am. J. Cardiol. 93, 1238–1242 (2004)PubMedCrossRef M.A. Albert, R.J. Glynn, J. Buring et al., C-reactive protein levels among women of various ethnic groups living in the United States (from the Women’s Health Study). Am. J. Cardiol. 93, 1238–1242 (2004)PubMedCrossRef
24.
go back to reference K.A. Matthews, M.F. Sowers, C.A. Derby et al., Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women’s Health Across the Nation (SWAN). Am. Heart J. 149, 1066–1073 (2005)PubMedCrossRef K.A. Matthews, M.F. Sowers, C.A. Derby et al., Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women’s Health Across the Nation (SWAN). Am. Heart J. 149, 1066–1073 (2005)PubMedCrossRef
25.
go back to reference G.D. Kolovou, D.P. Mikhailidis, J. Kovar et al., Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr. Vasc. Pharmacol. 9, 258–270 (2011)PubMedCrossRef G.D. Kolovou, D.P. Mikhailidis, J. Kovar et al., Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement. Curr. Vasc. Pharmacol. 9, 258–270 (2011)PubMedCrossRef
26.
go back to reference H.H. Hermsdorff, M.Á. Zulet, I. Abete et al., Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine 36, 445–451 (2009)PubMedCrossRef H.H. Hermsdorff, M.Á. Zulet, I. Abete et al., Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects. Endocrine 36, 445–451 (2009)PubMedCrossRef
27.
go back to reference A. Esteghamati, A. Zandieh, O. Khalilzadeh et al., Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine 38, 206–213 (2010)PubMedCrossRef A. Esteghamati, A. Zandieh, O. Khalilzadeh et al., Clustering of leptin and physical activity with components of metabolic syndrome in Iranian population: an exploratory factor analysis. Endocrine 38, 206–213 (2010)PubMedCrossRef
Metadata
Title
A hypertriglyceridemic state increases high sensitivity C-reactive protein of Japanese men with normal glucose tolerance
Authors
Kyoko Okada
Norihiro Furusyo
Masayuki Murata
Yasunori Sawayama
Mosaburo Kainuma
Jun Hayashi
Publication date
01-02-2012
Publisher
Springer US
Published in
Endocrine / Issue 1/2012
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-011-9532-8

Other articles of this Issue 1/2012

Endocrine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.